ArticleFrontiers in pharmacology2022

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs.

Christopher A Lipinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.